Anti-OX40 Antibodies, Ichnos Sciences, Apr 15
Summary
The European Patent Office published patent application EP3802600A1 assigned to Ichnos Sciences S.A., covering anti-OX40 antagonistic antibodies and dosage regimens for the treatment of OX40-mediated disorders. The application names Jonathan Back and Sachin Dubey as inventors, with IPC classifications in C07K 16/28 and A61K 39/395. The application designates 30 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.
What changed
The EPO published application EP3802600A1 covers anti-OX40 antagonist antibodies and associated dosage regimens for treating OX40-mediated disorders. Inventors Back and Dubey filed under IPC classifications C07K 16/28 and A61K 39/395. The application designates 30 European Contracting States, indicating broad geographic protection sought.
Pharmaceutical and biotechnology companies developing immunotherapies or OX40-targeting biologics should review the application's claims for potential overlap with their own R&D programs or existing IP portfolios. Freedom-to-operate analyses may be affected for parties active in the OX40/OX40L pathway space.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-OX40 ANTAGONISTIC ANTIBODIES AND DOSAGE FOR THE TREATMENT OF OX40-MEDIATED DISORDERS
Publication EP3802600A1 Kind: A1 Apr 15, 2026
Applicants
ICHNOS SCIENCES S.A.
Inventors
BACK, Jonathan, DUBEY, Sachin
IPC Classifications
C07K 16/28 20060101AFI20191206BHEP A61K 39/395 20060101ALI20191206BHEP A61P 37/08 20060101ALI20191206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.